A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT06568939

Public ClinicalTrials.gov record NCT06568939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 2:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

Study identification

NCT ID: NCT06568939
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: AbbVie; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Non-Small Cell Lung Cancer

Interventions

Telisotuzumab Vedotin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 19, 2025
Primary completion: Jan 31, 2028
Completion: Jan 31, 2028
Last update posted: Feb 22, 2026

2025 – 2028

United States locations

U.S. sites: 35
U.S. states: 21
U.S. cities: 34

Facility	City	State	ZIP	Site status
Ironwood Cancer & Research Center /ID# 276370	Chandler	Arizona	85224	Recruiting
University of Arkansas for Medical Sciences /ID# 272923	Little Rock	Arkansas	72205	Recruiting
Valkyrie Clinical Trials /ID# 271322	Los Angeles	California	90067	Recruiting
Yale New Haven Hospital /ID# 271584	New Haven	Connecticut	06510	Recruiting
Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 270899	Jacksonville	Florida	32256	Recruiting
Ocala Oncology Center /ID# 273697	Ocala	Florida	34474	Recruiting
Comprehensive Hematology Oncology /ID# 270422	St. Petersburg	Florida	33701-4732	Recruiting
Florida Cancer Specialists - North /ID# 271995	St. Petersburg	Florida	33705	Recruiting
Florida Cancer Specialists - East /ID# 271993	West Palm Beach	Florida	33401	Recruiting
University Cancer & Blood Center /ID# 270969	Athens	Georgia	30607	Recruiting
Northwest Georgia Oncology Centers /ID# 275374	Marietta	Georgia	30060	Recruiting
Memorial University Medical Center /ID# 272467	Savannah	Georgia	31404	Recruiting
Kaiser Permanente Moanalua Medical Center /ID# 272916	Honolulu	Hawaii	96819	Recruiting
University of Illinois Hospital and Health Sciences System /ID# 275345	Chicago	Illinois	60607	Recruiting
Illinois Cancer Specialists /ID# 274678	Niles	Illinois	60714	Recruiting
Springfield Clinic - First /ID# 272576	Springfield	Illinois	62702	Recruiting
NHO - Nebraska Hematology-Oncology /ID# 272970	Lincoln	Nebraska	68506	Recruiting
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271527	Omaha	Nebraska	68130	Recruiting
Renown Regional Medical Center /ID# 273535	Reno	Nevada	89502	Recruiting
Astera Cancer Care /ID# 272359	East Brunswick	New Jersey	08816-4096	Recruiting
Montefiore Medical Center /ID# 277169	The Bronx	New York	10461	Recruiting
Clinical Research Alliance - Westbury /ID# 270455	Westbury	New York	11590	Recruiting
FirstHealth of the Carolinas- Speciality Center /ID# 272924	Pinehurst	North Carolina	28374	Recruiting
Mercy Health - Perrysburg Cancer Center /ID# 270536	Perrysburg	Ohio	43551	Recruiting
Genesis Healthcare System /ID# 273361	Zanesville	Ohio	43701	Recruiting
Guthrie Robert Packer Hospital /ID# 270316	Sayre	Pennsylvania	18840	Recruiting
Cancer Care Associates Of York /ID# 270971	York	Pennsylvania	17403	Recruiting
Medical University of South Carolina /ID# 273272	Charleston	South Carolina	29425	Recruiting
Saint Francis Cancer Center - Greenville /ID# 276368	Greenville	South Carolina	29607	Recruiting
SCRI Oncology Partners /ID# 270162	Nashville	Tennessee	37203	Recruiting
Texas Oncology - Northeast Texas /ID# 272000	Tyler	Texas	75702	Recruiting
Community Cancer Trials Of Utah /ID# 276598	Ogden	Utah	84405	Recruiting
Virginia Cancer Specialists - Fairfax /ID# 272004	Fairfax	Virginia	22031	Recruiting
Medical Oncology Associates - Spokane /ID# 277172	Spokane	Washington	99208	Recruiting
Northwest Medical Specialties Tacoma /ID# 270534	Tacoma	Washington	98405	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06568939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 22, 2026 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06568939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →